Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-363 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate |
2006-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59bb718e4b6e7d7a525c57d123a80760 |
publicationDate |
2010-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7807645-B2 |
titleOfInvention |
Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment |
abstract |
The invention herein related to methods and compositions for treating nervous system disorders. The methods comprise peptides that bind to receptors important in disease progression, thus attenuating the disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019064152-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8569242-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11099172-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017003280-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8980836-B2 |
priorityDate |
2005-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |